r The prevalence of cardiorespiratory fitness (CRF) non-response gradually declines in healthy individuals exercising 60, 120, 180, 240 or 300 min per week for 6 weeks.
Introduction
Primary sources regarding the notion of physical activity as a means to preserve health emerged along with the inception of scientific medicine in ancient Greece (Potteiger, 2013) . More than 2 millennia later, outstanding health benefits associated with physical activity have been demonstrated by modern experimental, epidemiological and clinical sciences (Morris et al. 1953; Lee et al. 1995; Church et al. 2007; Wen et al. 2011; Pedersen & Saltin, 2015) . Daily vigorous exercise decreases cardiovascular, metabolic and all-cause mortality by 40-70%, irrespective of age, sex and presence of disease (Wen et al. 2011) . Many of these benefits are closely associated with improvements in cardiorespiratory fitness (CRF), as determined by maximal oxygen consumption (V O 2 max ) or incremental exercise power output (W max ), independent of traditional risk factors (Joyner & Green, 2009; Lee et al. 2010) . CRF is thus considered a key surrogate endpoint of exercise training interventions in healthy and diseased individuals (Laukkanen et al. 2001; Kodama et al. 2009 ).
Among exercise training modalities, CRF is particularly responsive to endurance training (ET).V O 2 max and W max commonly increase by an average of ß3-35% at the group level with regular ET in a dose (exercise duration × intensity)-dependent manner (Wenger & Bell, 1986; Church et al. 2007; Helgerud et al. 2007; Bouchard et al. 2011b; Bacon et al. 2013; Jacobs et al. 2013; Bonne et al. 2014; Montero et al. 2015a) .V O 2 max and W max gains induced by a given dose of supervised ET are, however, not uniform at the individual level, one-third of measurements being dispersed more than 1 standard deviation from the mean (Cohen & Holliday, 1979; Lortie et al. 1984; Bouchard et al. 2011b; Bacon et al. 2013) . Importantly, some individuals seemingly do not demonstrate any improvement inV O 2 max with ET according to current dose recommendations (150 min of moderate endurance exercise per week) (Bouchard et al. 2011b; Garber et al. 2011) . The prevalence ofV O 2 max non-responders has been reported to reach up to 20% among healthy individuals (Timmons et al. 2010) , raising compelling challenges to personalized preventive medicine (Buford et al. 2013) .
As a first step, it is fundamental to understand which factors contribute to interindividual differences in CRF trainability. In this regard, much attention has been paid to genetic determinants (Bouchard et al. 1999 (Bouchard et al. , 2011a Bouchard, 2012; Timmons et al. 2010; Sarzynski et al. 2017) . Twenty-one single-nucleotide polymorphisms were found to explain up to 50% of theV O 2 max individual response to 5 months of moderate ET in a cohort of 473 sedentary adults from the HERITAGE Family Study (HERITAGE henceforward) (Bouchard et al. 2011b) . Approximately 8% of these individuals increasedV O 2 max by 28% or more, whereas ß7% demonstrated a change inV O 2 max of only 4% or less (Bouchard et al. 2011b) .
While these findings have to be replicated, the notion has spread that CRF trainability is essentially a matter of fate (Roth, 2008; Bouchard, 2012; Mosley, 2012 ). Yet, it is uncertain whether HERITAGE outcomes can be extrapolated to at-risk or diseased populations and above all, it remains to be established whether or to what extent CRF non-response is dose-dependent.
The influence of ET dose on CRF non-response was recently examined in three groups of obese adults exposed to three distinct levels of exercise amount and intensity for 6 months (Ross et al. 2015) . CRF non-response, as defined by any change inV O 2 max lower than the typical error of measurement (TE), was observed in 39, 18 and 0% of obese individuals, respectively randomized to low-amount (180-300 kcal per session)-low-intensity (50%V O 2 max ), high-amount (360-600 kcal per session)-low-intensity (50%V O 2 max ) or high-amount (360-600 kcal per session)-high-intensity (75%V O 2 max ) of ET, all including four to five exercise sessions per week (Ross et al. 2015) . A similar decline in the prevalence ofV O 2 max non-responders was previously demonstrated in postmenopausal women allocated to four to five exercise sessions requiring 4, 8 or 12 kcal kg −1 per week during 6 months (Sisson et al. 2009 ). These studies therefore suggest that CRF non-response might ultimately be the result of inadequate exercise stimuli. Nonetheless, it should be noted that only individuals who adhered to at least 90% of the prescribed exercise sessions were included in these analyses (Sisson et al. 2009; Ross et al. 2015) . It thus cannot be discounted that non-responders were primarily excluded by study design. To unequivocally overcome this issue, CRF non-responders should first be identified and then subjected to higher dose ET (Mann et al. 2014 ). This may be ideally addressed using a repeated ET intervention, which likewise would limit the influence of within-subject response variability, a well-known source of confounding in the clinical arena but uncertain concerning exercise training studies (Senn et al. 2011; Hecksteden et al. 2015) .
Therefore, we assessed the response of CRF to ET in healthy young individuals divided into five groups comprising one, two, three, four or five 60 min exercise sessions per week during 6 weeks. We used this relatively short length of ET in order to secure a high prevalence of CRF non-responders while still provoking extensive physiological responses at the group level (Montero et al. 2015a) . Likewise, W max was chosen as the primary CRF outcome because its TE, as measured in our laboratory, is lower compared with that frequently reported forV O 2 max (ß5%) (Shephard et al. 2004) ; indeed, the relatively large contribution of test-retest errors iṅ V O 2 max to the individual response to ET has been a matter of controversy concerning seminal studies in the current subject (Shephard et al. 2004; Hecksteden et al. 2015) . Individuals identified as non-responders subsequently completed an identical 6-week ET period but including two additional exercise sessions per week, thereby augmenting the ET dose dispensed. In addition, V O 2 max as well as potential haematological and skeletal muscle determinants of W max were assessed prior to and after each ET period with the intent to determine physiologically relevant parameters that may explain variations in trainability.
Methods

Participants
Seventy-eight healthy young male volunteers [age (mean ± SD) = 26.2 ± 3.4 years, height (mean ± SD) = 180.8 ± 4.3 cm] were recruited to participate in the study. To this end, ads were placed at the university campus looking for untrained individuals. As inclusion criteria, individuals had to be to males between 18 and 35 years of age not participating in organized sports, non-smokers and medication free. Cycling and walking for commuting purposes were allowed. The protocol was approved by the local ethical committee (EK 2011-N-51) and conducted in accordance with the Declaration of Helsinki. Prior to the start of the experiments, informed oral and written consents were obtained from all participants.
Experimental design
All individuals underwent a first period of supervised training for 6 weeks consisting of 60 min sessions of cycle ergometer exercise. Individuals could chose to participate in five groups differing in the number of exercise sessions per week. Groups 1, 2, 3, 4 and 5 performed one, two, three, four and five exercise sessions per week, respectively, corresponding to 60, 120, 180, 240 and 300 min per week in total. Four different intensity profiles, comprising moderate continuous exercise and high-intensity intervals, were alternated to facilitate participant motivation and compliance, as detailed previously .
Profile 1 consisted of a steady-state exercise, i.e. 60 min at 65% of peak power output (W max ) attained with the incremental exercise test.
Profile 2 started with 11.25 min at 65% of W max followed by 0.5 min at 130%, 1.25 min at 50%, 0.5 min at 130%, 1 min at 50%, 11.25 min at 65%, 0.5 min at 130%, 1.25 min at 50%, 0.5 min at 130%, 1.25 min at 50%, 0.5 min at 130%, 1 min at 50%, 11.25 min at 65%, 0.5 min at 130%, 1.25 min at 50%, 0.5 min at 130%, 1.25 min at 50%, 0.5 min at 130%, 1.25 min at 50%, 0.5 min at 130%, 1 min at 50% and 11.25 min at 65% W max .
Profile 3 started with 3 min at 50% of W max followed by 3 min at 60%, 3 min at 65%, 3 min at 70%, 3 min at 75%, 3 min at 70%, 3 min at 65%, 3 min at 60%, 3 min at 50%, 3 min at 65%, 3 min at 5%, 3 min at 60%, 3 min at 65%, 3 min at 70%, 3 min at 75%, 3 min at 70%, 3 min at 65%, 3 min at 60%, 3 min at 50% and 3 min at 65% W max .
Profile 4 started with 6 min at 65% of W max followed by 4 min at 75%, 6 min at 65%, 4 min at 75%, 6 min at 65%, 4 min at 75%, 6 min at 65%, 4 min at 75%, 6 min at 65%, 4 min at 75%, 6 min at 65% and 4 min at 75% W max .
Each profile had an average exercise intensity of 65% of W max for 60 min. Workloads were calculated from individual W max determined during the incremental exercise test at baseline. CRF non-response was determined using the TE (Hopkins, 2000) . TE is a measure of technological error and day-to-day biological variation. It was calculated by the standard error of within-subject standard deviation from duplicate W max assessments, and expressed as a percentage of the individual's mean W max (i.e. in the form of a coefficient of variation). Any percentage change in W max not beyond ±1 × %TE was considered a non-response. Based on repeated testing at baseline in all individuals, CRF non-response was calculated to be ±3.96% for W max . The average of duplicate W max assessments was considered the baseline W max for each individual. Less than 7 days after the end of the initial ET period, non-responders in each exercise group started a second 6-week ET program identical to the former but adding two exercise sessions per week. The measures described below were determined prior to and after the first ET period as well as following the second ET period.
Experimental measures
Incremental exercise test. W max andV O 2 max were determined on an electronically braked bicycle ergometer (Monark, Vansbro, Sweden) with continuous measurements ofV O 2 using an online gas collection system (Innocor M400, Innovision, Glamsbjerg, Denmark). The test started with a warm-up period of 5 min at 50-150 W workloads. Thereafter, the workload was increased by 30 W every 60 s until exhaustion. The gas analysers and the flowmeter of the applied spirometer were calibrated prior to each test. Breath-by-breath values were averaged over 30 s. The highest average value was taken as thė V O 2 max provided that standard criteria were fulfilled (American Thoracic Society, 2003) . W max was calculated as W compl + 30(t/60), where W compl is the last fully completed workload and t is the number of seconds in the final workload.
Blood. Haemoglobin mass (Hb mass ) was measured as previously described (Siebenmann et al. 2015) , using a modified version of the carbon monoxide (CO) re-breathing technique (Burge & Skinner, 1995) . All individuals rested for 20 min in a semi-recumbent position before each measurement. Thereafter, 2 ml of blood was sampled from an antecubital vein via a 20-G venflon catheter (BD, Franklin Lakes, NJ, USA) and J Physiol 595.11 analysed immediately in quadruplicate for (i) percentage carboxyhaemoglobin and Hb concentration ([Hb]) using a haemoximeter (ABL800, Radiometer, Denmark), and (ii) haematocrit (Hct) with the micromethod (4 min at 13,500 rpm). Subsequently, the subject breathed 100% oxygen for 4 min to flush the nitrogen from the airways. After closing the oxygen input, a bolus 1.5 ml kg −1 of 99.997% chemically pure CO (CO N47, Air Liquide, Paris, France) was administrated into the breathing circuit. The subjects rebreathed this gas mixture for 10 min. Then, an additional 2 ml blood sample was obtained and analysed in quadruplicate. The change in percentage carboxyhaemoglobin was used to calculate Hb mass , taking into account the amount of CO that remained in the rebreathing circuit at the end of the procedure (2.2%) (Burge & Skinner, 1995) . Total red blood cell volume (RBCV), blood volume (BV) and plasma volume (PV) were derived from measures of Hb mass and Hct (Burge & Skinner, 1995) . (Bergstrom, 1962 ) with a needle modified for suction, skeletal muscle biopsies from m. vastus lateralis were obtained under local anaesthetics while the subject was at rest with a minimum of 24 h following the last exercise training bout. The biopsy specimen was dissected free of fat and connective tissue, divided into sections and immediately prepared for analysis as stated below.
Skeletal muscle biopsies. Using the Bergström technique
Mitochondrial volume density. Four 1 mm 3 pieces of each muscle biopsy were fixed in 2.5% glutaraldehyde at room temperature and processed according to standard electron-microscopy protocols. Transition electron microscopy images were obtained in a FEI Tecnai G2 Spirit electron microscope (FEI, Hillsboro, OR, USA) with an Orius SC1000 CCD camera (Gatan, Pleasanton, CA, USA) and interfaced with the transition electron microscope user software (from FEI). Two hundred and sixteen images per biopsy were acquired in a random systematic order from 24 meshes distributed on eight grids from four blocks. The Cavalieri feature in the Stereo-Investigator software (MBF Bioscience, Williston, VT, USA) was used to estimate mitochondrial volume density (Mito VD ) by point counting (West, 2012) . The grid spacing was 1 μm along both x-and y-axes. Mitochondria boundaries were recognized at the x8200 magnification. Each point was assigned as one of mitochondria, muscle or 'nothing' . Mito VD was expressed as the percentage of muscle tissue occupied by mitochondria. Mito VD was not assessed after the second training period.
Statistical analysis
Statistical analyses were performed using SPSS Statistics v. 22.0 (IBM Corp., Armonk, NY, USA). Data were tested for normal distribution with the Kolmogorov-Smirnov test and for homogeneity of variances with Levene's test. One-way ANOVA with Bonferroni correction for multiple comparisons was used to compare continuous baseline variables among groups. To examine the impact of the frequency of exercise sessions on the effects of exercise training, a one-way ANOVA was applied including baseline values as covariates and Bonferroni correction for multiple comparisons. When F was significant in the ANOVA, planned pair-wise specific comparisons were carried out. Effects of exercise training on studied variables in each group were assessed by Student's paired t test. The proportion of CRF non-responders was compared among groups with the chi-square test. Finally, multiple regression analysis was used to identify variables independently associated with absolute changes (post-training minus pre-training, ) in W max oṙ V O 2 max , including first and second ET periods. Variables significantly associated with W max or V O 2 max in univariate analyses, as determined by Pearson's correlation coefficients, were entered into the regression model as independent variables. In the case of high correlation between independent variables, each of these were separately entered into the regression model in order to avoid high multicollinearity (variance inflation factor >10). A two-tailed P-value less than 0.05 was considered significant. Data are reported as the mean (±SD) unless otherwise stated.
Results
Baseline
Characteristics of study groups prior to ET are summarized in Table 1 . Body weight, haematological values (Hct, Hb, Hb mass , PV, RBCV, BV), skeletal muscle Mito VD andV O 2 max were similar between groups (P > 0.05). The only difference between groups was observed with regard to W max , which was higher in group 5 compared with group 3 as expressed in either absolute (W) or relative (W kg −1 ) units (P < 0.05). Table 2 presents absolute changes ( ) after the first ET period in each group. A decrease in body weight with training was only observed in groups 4 and 5 (P < 0.05).
First exercise training period
Mito VD increased in all groups (P < 0.05). Hb mass , RBCV, BV,V O 2 max and W max increased in all groups (P < 0.05) except for group 1. With respect to the comparisons of among groups, body weight was lower (negative) in group 5 compared with groups 1, 2 and 3 (P < 0.05). Moreover, Mito VD was higher in groups 4 and 5 versus groups 1 and 2 (P < 0.05). Hb mass , RBCV, BV and V O 2 max were higher in group 5 compared with any other group (P < 0.05). W max was higher in groups 4 and 5 versus groups 1, 2 and 3 (P < 0.05). Analyses with percentage (instead of ) changes and/or without covariate adjustment gave similar results. Figure 1 illustrates individual percentage changes in W max after the first ET period. The prevalence of W max non-response was 69% (11 of 16 individuals), 40% (6 of 15), 29% (4 of 14), 0% (0 out of 17) and 0% (0 out of 16) for groups 1, 2, 3, 4 and 5, respectively (P < 0.001). The average percentage change in W max of non-responder individuals was −1%, −1% and 2% for groups 1, 2 and 3, respectively. Whilst not measured in the current study, provided a TE forV O 2 max of 5% (Shephard et al. 2004) , the prevalence ofV O 2 max non-response would be 81% (13 of 16 individuals), 47% (7 of 15), 50% (7 of 14), 18% (3 out of 17) and 0% (0 out of 16) for groups 1, 2, 3, 4 and 5, respectively.
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Second exercise training period
Non-responders to the first ET period subsequently performed a second ET intervention including two additional training sessions per week. Paired comparisons were performed after the second ET period versus baseline (prior to the first ET period) in non-responder individuals, thus assessing the total impact of both training periods in each group (n = 11, group 1 + 2; n = 6, group 2 + 2; n = 4, group 3 + 2). Body weight decreased in group 2 + 2 (P < 0.05). Hb mass , RBCV, BV,V O 2 max and W max increased in all groups (1 + 2, 2 + 2, 3 + 2; P < 0.05). Mito VD was not assessed after the second ET period. Analyses with percentage (instead of ) changes and/or without covariate adjustment gave similar results. Figure 2 displays individual percentage changes in W max after the first and second ET periods for non-responder individuals. Non-response was not observed after the second ET period in any individual.
Determinants of changes in W max and V O2max
In univariate analysis, V O 2 max (r = 0.85, P < 0.001), Hb mass (r = 0.64, P < 0.001), RBCV (r = 0.62, P < 0.001), BV (r = 0.53, P < 0.001), PV (r = 0.42, P < 0.001) and Mito VD (r = 0.26, P = 0.043) were positively whereas body weight (r = −0.29, P = 0.003) was negatively associated with W max . Moreover, Hb mass (r = 0.64, P < 0.001), RBCV (r = 0.62, P < 0.001), BV (r = 0.52, P < 0.001) and PV (r = 0.42, P < 0.001) were positively and body weight (r = -0.25, P = 0.012) negatively associated with V O 2 max . Accordingly, Hb mass , RBCV, PV, BV, Mito VD , V O 2 max and body weight were entered into the regression model as potential independent determinants of W max (Table 3) , while Hb mass , RBCV, PV, BV and body weight were entered as potential independent determinants of V O 2 max (Table 4) . V O 2 max remained the only variable independently associated with W max (β = 0.08, r partial ࣙ 0.74, P < 0.001). In turn, Hb mass was the strongest independent determinant of V O 2 max (β = 3.26, r partial = 0.49, P < 0.001).
Discussion
The present study tested the prevalence of CRF non-response, as defined by any change of W max not surpassing %TE, with a double 6-week ET protocol in 78 healthy individuals. The key findings are the following: (i) after the first ET period, the prevalence of CRF V O 2 max , maximal oxygen consumption; W max , maximal power output; , post-minus pre-training absolute change. Hb mass , RBCV and PV were closely correlated with BV in bivariate analyses (r > 0.80, P < 0.0001), and thus these variables were appropriately entered into a regression model in order to avoid high multicollinearity (variance inflation factor >10). Values in bold are significant. β, unstandardized regression coefficient withV O 2 max (ml) as outcome; BV, blood volume; CI, confidence interval; Hb mass , haemoglobin mass; PV, plasma volume; RBCV, red blood cell volume; r partial , partial correlation coefficient;V O 2 max , maximal oxygen consumption; , post minus pre training absolute change. Hb mass , RBCV and PV were closely correlated with BV in bivariate analyses (r > 0.80, P < 0.0001), thus these variables were appropriately entered into a regression model in order to avoid high multicollinearity (variance inflation factor > 10). Values in bold are significant.
non-response was 69, 40 and 29% in individuals training for 60, 120 and 180 min per week, respectively, and was absent (0%) in those training for 240 and 300 min per week; (ii) CRF non-response was completely eliminated following the second 6-week ET period including two extra 60 min sessions per week; and (iii) CRF (non-)response was underlain by changes in Hb mass . While the existence of interindividual response variability to exercise training is beyond dispute, less convincing is the generalized idea that a substantial fraction (ß20%) of individuals fail to improve CRF following intense ET (Timmons et al. 2010) . Supporting evidence primarily derives from HERITAGE, in which 473 Caucasian adults (51% females) completed three exercise sessions per week progressively increasing their length from 30 to 50 min and intensity from 55% to 75% of maximal heart rate (HR max ), during 5 months (Bouchard et al. 1995; Timmons et al. 2010) . The HERITAGE J Physiol 595.11 ET program thus reached the low end of current recommendations as regards exercise time per week (150 min) and did not comprise high intensity exercise (ࣙ 80% HR max ) (Garber et al. 2011) . Of note, since exercise intensity was controlled by heart rate monitoring, interindividual fluctuations in training workload did occur and partly explainedV O 2 max responses to ET in HERITAGE (Sarzynski et al. 2016) . Most importantly, meta-analytical evidence encompassing research performed during the last four decades suggests that higher doses of ET than those prescribed in HERITAGE can generate substantial improvements inV O 2 max in nearly all young and middle-aged adults (Bacon et al. 2013) . Likewise, recent studies have observed gradual decreases in the number of CRF non-responders with increasing doses of ET in individuals who completed ࣙ 90% of the exercise sessions prescribed (Sisson et al. 2009; Ross et al. 2015) . A key limitation of these studies, however, is the potential presence of CRF non-responders in individuals who dropped out or failed to complete the minimum number of exercise sessions. Definitive proof that CRF non-responders may benefit from higher ET doses can only be provided by within-subject study designs (Mann et al. 2014; Hecksteden et al. 2015) , as originally applied in the current study and discussed hereunder.
We sought to determine CRF trainability with a repeated 6-week ET intervention combining moderate continuous with high intensity exercise intervals in 60 min sessions. In the first ET period, individuals from five groups only differing in the number of sessions (1-5) and thus exercise dose per week were compared. In more than 20% of individuals allocated to one (60 min), two (120 min) or three (180 min) sessions of ET per week, W max did not increase (−1, −1 and 2%, respectively) more than 1 × %TE (4%) and hence they were considered as CRF non-responders. Afterwards, CRF non-responders accomplished a second ET period including 2 × 60 min additional sessions per week of otherwise identical training. After this additional training period CRF non-response was no longer present in any individual. This unequivocally demonstrates that CRF non-response was not inexorably predetermined in the study subjects and suggests that the potential for CRF improvements might well be present and unveiled with appropriate stimuli in healthy individuals without exception. Such unanimous CRF response may also indicate a relatively minor influence of within-subject response variability and measurement error when applying successive higher doses of ET (Bacon et al. 2013; Hecksteden et al. 2015) . Despite our data clearly denoting the spurious nature of CRF non-response, a wide interindividual variability in CRF improvements to identical ET dose is plainly illustrated in Figs 1 and 2 . Certainly, hereditary factors must be assumed to play a role on CRF trainability (Bouchard et al. 1999) , although family-and large population-based confirmatory/replication studies are needed (Thomis, 2008) . In addition, an often overlooked factor is the typical use of some percentage of HR max , V O 2 max or W max to prescribe exercise intensity, which does not effectively standardize the homeostatic stress caused by ET at the individual level (Meyer et al. 1999; Gaskill et al. 2001; Scharhag-Rosenberger et al. 2010) . Therefore, provided a given ET dose, individuals may experience diverse magnitudes of stimuli for adaptive responses. Furthermore, a perfectly identical exercise dose prescription for any individual may prompt distinct homeostatic stress according to its interaction with oscillating factors such as sleep and nutrition, both affecting recovery and readiness to train (Kentta & Hassmen, 1998; Samuels, 2009; Hawley et al. 2011) . Collectively considered, a comparable homeostatic stress among individuals involved in ET, as commonly prescribed, seems unlikely (Mann et al. 2014) . It follows that a certain degree of interindividual variability in CRF trainability to a fixed ET dose may be generally expected by default due to lack of truly standardized exercise stimuli.
The question arises as to whether variability in CRF response to ET lies upon a firm mechanistic basis. ET is commonly associated with a surfeit of phenotypic modifications along the O 2 transport and utilization chain -from lung to mitochondria -all potentially contributing toV O 2 max and W max improvements via enhancing convective oxygen delivery to and/or extraction by active tissue (Hawley & Noakes, 1992; Helgerud et al. 2007; Boushel et al. 2011; Lundby & Montero, 2015; Montero et al. 2015a; Wagner, 2015) . The bulk of evidence indicates that haemodynamic and haematological systemic adaptations increasing the capacity to deliver oxygen predominantly explainV O 2 max improvements with short-term (5-11 weeks) ET in healthy individuals (Montero & Diaz-Canestro, 2015; Montero et al. 2015b) . Empirical evidence demonstrates that the increase inV O 2 max with 6 weeks of moderate-to-high intensity ET is primarily attributed to augmented circulating RBCV and oxygen-carrying capacity of blood, as reflected by increases in total circulating Hb mass Montero et al. 2015a) . In turn, increases in skeletal muscle capillarization and Mito VD , both possibly facilitating oxygen extraction, do not seem to contribute substantially to the increase inV O 2 max after 6 weeks of ET (Montero et al. 2015a) . Concurring with the above, in the present study increases () in Hb mass were the strongest determinants of V O 2 max , which in turn explained most of the variance in W max . Yet, approximately half of the variance in V O 2 max remained unexplained, which could be partially attributed to non-assessed adaptations modulating cardiac output and its distribution (Boushel et al. 2014; Lundby et al. 2017) . The parallelism between changes inV O 2 max and underlying phenotypic modifications measured in this study implies the presence of quantitative but not major qualitative differences in either homeostatic stress induced by ET or adaptive capacity on an individual basis. Ultimately, it is worth noticing that the genetic bases of crucial physiological pathways governing convective oxygen delivery have not been identified (Sarzynski et al. 2016) .
Another important outcome of this study was the magnitude of increases in CRF at the group level according to ET dose. Increases in W max with 240 or 300 min were substantial (24 and 32%) and higher compared with uniformly small W max changes observed with 60, 120 or 180 min of training per week (1, 5 and 7%, respectively) (Fig. 1) . Similar findings were obtained regardingV O 2 max (Fig. 3) . Part of this gap could be attributed to lower Hb mass in the 300 min group prior to ET (P = 0.064) facilitating greater adaptations, albeit baseline values were included as covariates. Regardless, the critical duration of exercise for CRF improvements with moderate-high intensity ET may lie somewhere between > 180 ࣘ 240 min per week for most individuals. This finding concurs with previous reports suggesting raising the minimum level of exercise dose in physical activity guidelines for healthy adults (Bacon et al. 2013; Ross et al. 2015) .
Limitations
Findings were obtained from a sample of healthy young males. Further research will elucidate whether current conclusions can be extrapolated to populations including females, older individuals and/or cardio-metabolic patients. Moreover, this study was designed to dissect the independent contribution of overall ET dose, but not of its components (frequency/length of exercise sessions, total duration, intensity). In addition,V O 2 max measurements were not duplicated at baseline and therefore %TE foṙ V O 2 max was not calculated. Nonetheless,V O 2 max and W max responses were closely associated and all W max non-responders increased theirV O 2 max with higher ET dose (Figs 3 and 4) . Finally, changes in body composition potentially influencing CRF were not assessed.
Conclusion
This study fundamentally challenges the notion of CRF non-response to exercise training. In 78 healthy individuals performing moderate-to-high intensity ET for 6 weeks, the prevalence of CRF non-response, as determined by W max , gradually declined in individuals exercising 60, 120 or 180 min per week. No vestige of W max non-response was observed in individuals training 240 or 300 min per week. Following a successive 6-week ET period comprising 120 min of additional ET per week, W max non-response was universally abolished. Consistent with sound experimental evidence, haematological adaptations in oxygen-carrying capacity underlayV O 2 max and thereby W max (non-)responses to ET. These findings highlight the J Physiol 595.11 need to re-evaluate contemporary concepts about human untrainability and exercise prescription.
